Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-02-13

FDA Approved: ULORIC — Original Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved ULORIC (febuxostat) as the original application to treat hyperuricemia associated with gout by lowering serum uric acid levels. The product is manu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Uloric (febuxostat)

Snippet

ORIG AP for ULORIC (FEBUXOSTAT)